Literature DB >> 12027955

Adhesion and entry of uropathogenic Escherichia coli.

Matthew A Mulvey1.   

Abstract

To effectively colonize a host animal and cause disease, many bacterial pathogens have evolved the mechanisms needed to invade and persist within host cells and tissues. Recently it was discovered that uropathogenic Escherichia coli, the primary causative agent of urinary tract infections, can invade and replicate within uroepithelial cells. This can provide E. coli with a survival advantage, allowing the microbes to better resist detection and clearance by both innate and adaptive immune defence mechanisms. Adhesive organelles, including type 1, P, and S pili along with Dr adhesins, promote both bacterial attachment to and invasion of host tissues within the urinary tract. Interactions mediated by these adhesins can also stimulate a number of host responses that can directly influence the outcome of a urinary tract infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027955     DOI: 10.1046/j.1462-5822.2002.00193.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  98 in total

1.  P pilus assembly motif necessary for activation of the CpxRA pathway by PapE in Escherichia coli.

Authors:  Yvonne M Lee; Patricia A DiGiuseppe; Thomas J Silhavy; Scott J Hultgren
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

2.  Switching and growth for microbial populations in catastrophic responsive environments.

Authors:  Paolo Visco; Rosalind J Allen; Satya N Majumdar; Martin R Evans
Journal:  Biophys J       Date:  2010-04-07       Impact factor: 4.033

3.  Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.

Authors:  Matthew G Blango; Matthew A Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

4.  Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.

Authors:  Mark A Smith; Rebecca A Weingarten; Lisa M Russo; Christy L Ventura; Alison D O'Brien
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

5.  The role of Escherichia coli in inflammatory bowel disease.

Authors:  Jonathan M Rhodes
Journal:  Gut       Date:  2007-05       Impact factor: 23.059

6.  Adaptor function of PapF depends on donor strand exchange in P-pilus biogenesis of Escherichia coli.

Authors:  Yvonne M Lee; Karen W Dodson; Scott J Hultgren
Journal:  J Bacteriol       Date:  2007-05-11       Impact factor: 3.490

7.  Persistence of uropathogenic Escherichia Coli in the bladders of female patients with sterile urine after antibiotic therapies.

Authors:  Shu-Cheng Liu; Xiao-Min Han; Ming Shi; Zi-Li Pang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

Review 8.  A review on anti-adhesion therapies of bacterial diseases.

Authors:  Arezoo Asadi; Shabnam Razavi; Malihe Talebi; Mehrdad Gholami
Journal:  Infection       Date:  2018-10-01       Impact factor: 3.553

9.  The Cpx stress response system potentiates the fitness and virulence of uropathogenic Escherichia coli.

Authors:  Irina Debnath; J Paul Norton; Amelia E Barber; Elizabeth M Ott; Bijaya K Dhakal; Richard R Kulesus; Matthew A Mulvey
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

Review 10.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.